F

ile this under “What were they thinking?”

For the second time this year, Pfizer has made substantial price hikes on some of its medicines, a move that disregards blistering criticism of the pharmaceutical industry over the cost of prescription drugs.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • geee,,,maybe its because all MEDICINE manufacturers are being sued by Adults who’s 30 year old ,”babies,”choose to use medicines like idiots,,,,,,maryw

  • If one wants to ‘observe’ that ‘Big Pharma’ is … uh, ‘s______g’ the customers, then using price increases on ‘the little blue pill’ is a fine point of emphasis.

  • New normal when one cannot create and develop new drugs for masses or expensive drugs for limited patients. Revenue has to go up to look good.

    • Shall we call this a ‘side effect’ of the Viagra patent extension to March 2020?

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.